Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes. (Q50496715)
Jump to navigation
Jump to search
scientific article published on 2 May 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes. |
scientific article published on 2 May 2012 |
Statements
1 reference
Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes. (English)
1 reference
1 reference
William McCoull
1 reference
Matthew S Addie
1 reference
Alan M Birch
1 reference
Susan Birtles
1 reference
Linda K Buckett
1 reference
Roger J Butlin
1 reference
Suzanne S Bowker
1 reference
Scott Boyd
1 reference
Stephen Chapman
1 reference
Robert D M Davies
1 reference
Craig S Donald
1 reference
Clive P Green
1 reference
Chloe Jenner
1 reference
Paul D Kemmitt
1 reference
Graeme C Moody
1 reference
Pablo Morentin Gutierrez
1 reference
Nicholas J Newcombe
1 reference
Thorsten Nowak
1 reference
Martin J Packer
1 reference
Alleyn T Plowright
1 reference
John Revill
1 reference
Paul Schofield
1 reference
Chris Sheldon
1 reference
Steve Stokes
1 reference
Andrew V Turnbull
1 reference
Steven J Y Wang
1 reference
David P Whalley
1 reference
J Matthew Wood
1 reference
2 May 2012
1 reference
22
1 reference
3873-3878
1 reference
12
1 reference
Identifiers
1 reference